Lion Street Advisors LLC Has $344,000 Stock Position in SPDR S&P Biotech ETF $XBI

Lion Street Advisors LLC decreased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 4,148 shares of the exchange traded fund’s stock after selling 220 shares during the period. Lion Street Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $344,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Investment Partners Asset Management Inc. boosted its position in shares of SPDR S&P Biotech ETF by 4.0% in the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock worth $270,000 after buying an additional 125 shares during the period. Compass Ion Advisors LLC boosted its position in SPDR S&P Biotech ETF by 3.9% during the 2nd quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock worth $309,000 after acquiring an additional 140 shares during the period. McAdam LLC boosted its position in SPDR S&P Biotech ETF by 5.1% during the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 159 shares during the period. First Heartland Consultants Inc. boosted its position in SPDR S&P Biotech ETF by 2.7% during the 1st quarter. First Heartland Consultants Inc. now owns 6,344 shares of the exchange traded fund’s stock worth $514,000 after acquiring an additional 168 shares during the period. Finally, Calton & Associates Inc. boosted its position in SPDR S&P Biotech ETF by 3.2% during the 1st quarter. Calton & Associates Inc. now owns 5,662 shares of the exchange traded fund’s stock worth $459,000 after acquiring an additional 175 shares during the period.

SPDR S&P Biotech ETF Trading Up 0.3%

Shares of NYSEARCA XBI opened at $105.27 on Tuesday. The firm has a market capitalization of $6.23 billion, a PE ratio of 11.47 and a beta of 0.97. The business has a 50-day moving average price of $94.35 and a two-hundred day moving average price of $85.92. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $107.26.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.